Ken Griffin Icosavax, Inc. Put Options Transaction History

Citadel Advisors LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$5.95 - $15.79 $29,750 - $78,950	5,000 Added 166.67%	8,000 $126,000
Q3 2023 Nov 14, 2023	BUY	$7.22 - $10.05 $6,498 - $9,045	900 Added 42.86%	3,000 $23,000
Q2 2023 Aug 14, 2023	SELL	$4.89 - $10.57 $13,692 - $29,596	-2,800 Reduced 57.14%	2,100 $20,000
Q1 2023 May 15, 2023	SELL	$5.62 - $11.51 $79,804 - $163,442	-14,200 Reduced 74.35%	4,900 $28,000
Q4 2022 Feb 14, 2023	BUY	$2.32 - $10.97 $44,312 - $209,527	19,100 New	19,100 $151,000

1.37M

Ticker ICVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,885,200
Description
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.